Summit Speaker Series: R. Nathan Slotnick, MD, PhD
07 July, 2016
The 2016 Nevada Cancer Control Summit brings together expert speakers from throughout the region to discuss the latest topics in cancer control. In the months leading up to this year’s Summit, scheduled for September 15 at Springs Preserve in Las Vegas, join us to learn more about our roster of speakers.
Precision medicine, at the heart of the Vice President’s Cancer Moonshot, has rocketed into visibility over the past several years and is at the heart of this year’s Cancer Control Summit theme. What’s on the horizon for precision medicine in terms of prevention, early detection, and treatment? And, what’s already happening in Nevada? Join R. Nathan Slotnick, MD, PhD, of Perinatal Associates in Reno as he discusses this and much more during our keynote presentation.
Dr. Slotnick is a Perinatologist at Perinatal Associates of Northern Nevada and Medical Geneticst at Cancer Genetics Risk Assessment. He has a master’s degree in Molecular Genetics from the University of Washington and a doctorate degree from the State University of New York, Buffalo. He earned his medical degree from the University of Pittsburgh and completed his residency and Fellowship training at University of California San Francisco and has served as Assistant Professor at the University of California, Davis (Maternal-Fetal Medicine) and Associate Professor at Eastern Virginia Medical School (Maternal-Fetal Medicine).
As a medical geneticist, Dr. Slotnick oversees a team of genetic counselors to provide genetic counseling and testing to people at increased risk for hereditary cancer, which can assist them to make informed medical decisions based on their own personal risk assessment.
Join us for this presentation and more at the 2016 Nevada Cancer Control Summit. Registration is $95 at the early bird rate through Aug. 12 and includes CE, handouts, lunch, and networking opportunities. Review the entire agenda and register online here.
You May Also Like
Knowing family history can be vital for reducing cancer risk
Recently, NCC’s Valerie Martinez, our Southern Nevada Outreach Coordinator, underwent genetic testing to determine if she had
ECHO: Cancer as a Genetic Issue
In this 2019 ECHO session, Dr. Nathan Slotnick defines genetics and genomics in cancer prevention and treatment.
NCI Lectures: Intercepting Lung Cancer via the Airway Transcriptome
This lecture is part of the National Cancer Institute's 2020 Annual Advances in Cancer Prevention Lecture Series